Trial Profile
Clinical Trials Insight: 700057631
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2010
Price :
$35
*
At a glance
- Drugs ADX 71149 (Primary)
- Indications Anxiety
- Focus Therapeutic Use
- Sponsors Addex Therapeutics
- 25 Aug 2010 Now the phase I programme is complete, enrollment is expected to begin in the first quarter of 2011, according to an Addex Pharmaceuticals media release.
- 13 Jul 2010 A phase II study of ADX 71149 is expected to start in 2010, according to an Addex Pharmaceuticals media release.
- 13 Jul 2010 New trial record